Zuzana Chyra

Ostrava, MO 70200, Czech Republic

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 22 publications

Decoding Waldenström Macroglobulinemia Through Genomics, Epigenomics and Cellular Interactions.

Decoding Waldenström Macroglobulinemia Through Genomics, Epigenomics and Cellular Interactions.

Journal: International journal of molecular sciences
Published: April 25, 2026

The Evolving Role of Genomic Technologies in Multiple Myeloma: Implications for Diagnosis, Risk Stratification and Resistance.

The Evolving Role of Genomic Technologies in Multiple Myeloma: Implications for Diagnosis, Risk Stratification and Resistance.

Journal: Molecular diagnosis & therapy
Published: October 22, 2025

Novel immunotargets in multiple myeloma: biological relevance and therapeutic potential.

Novel immunotargets in multiple myeloma: biological relevance and therapeutic potential.

Journal: Biomarker research
Published: February 17, 2025

BRCA1 and BRCA2 as prognostic markers in oral squamous cell carcinoma: a minireview.

BRCA1 and BRCA2 as prognostic markers in oral squamous cell carcinoma: a minireview.

Journal: Frontiers in oncology
Published: November 15, 2024

Deubiquitinase BAP1 is crucial for surface expression of T cell receptor (TCR) complex, T cell-B cell conjugate formation, and T cell activation.

Deubiquitinase BAP1 is crucial for surface expression of T cell receptor (TCR) complex, T cell-B cell conjugate formation, and T cell activation.

Journal: Journal of leukocyte biology
Published: July 15, 2024

Impact of T cell characteristics on CAR-T cell therapy in hematological malignancies.

Impact of T cell characteristics on CAR-T cell therapy in hematological malignancies.

Journal: Blood cancer journal
Published: June 20, 2024

Beyond the marrow: insights from comprehensive next-generation sequencing of extramedullary multiple myeloma tumors.

Beyond the marrow: insights from comprehensive next-generation sequencing of extramedullary multiple myeloma tumors.

Journal: Leukemia
Published: December 12, 2023

Enhancing oral squamous cell carcinoma prediction: the prognostic power of the worst pattern of invasion and the limited impact of molecular resection margins.

Enhancing oral squamous cell carcinoma prediction: the prognostic power of the worst pattern of invasion and the limited impact of molecular resection margins.

Journal: Frontiers in oncology
Published: September 02, 2023

Insight into the mechanism of CD34+ cell mobilisation impairment in multiple myeloma patients treated with anti-CD38 therapy.

Insight into the mechanism of CD34+ cell mobilisation impairment in multiple myeloma patients treated with anti-CD38 therapy.

Journal: British journal of haematology
Published: August 06, 2023

Transcriptome Analysis of Diffuse Large B-Cell Lymphoma Cells Inducibly Expressing MyD88 L265P Mutation Identifies Upregulated CD44, LGALS3, NFKBIZ, and BATF as Downstream Targets of Oncogenic NF-κB Signaling.

Transcriptome Analysis of Diffuse Large B-Cell Lymphoma Cells Inducibly Expressing MyD88 L265P Mutation Identifies Upregulated CD44, LGALS3, NFKBIZ, and BATF as Downstream Targets of Oncogenic NF-κB Signaling.

Journal: International journal of molecular sciences
Published: February 11, 2023

Tuning CARs: recent advances in modulating chimeric antigen receptor (CAR) T cell activity for improved safety, efficacy, and flexibility.

Tuning CARs: recent advances in modulating chimeric antigen receptor (CAR) T cell activity for improved safety, efficacy, and flexibility.

Journal: Journal of translational medicine
Published: February 08, 2023

More Than 2% of Circulating Tumor Plasma Cells Defines Plasma Cell Leukemia-Like Multiple Myeloma.

More Than 2% of Circulating Tumor Plasma Cells Defines Plasma Cell Leukemia-Like Multiple Myeloma.

Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: October 31, 2022
Showing 1-12 of 22

Last Updated: 09/26/2026